Michael Morabito
Stock Analyst
(n/a)
# 4,474
Out of 4,479 analysts
10
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
5 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AKRO Akero Therapeutics | Maintains: Buy | n/a | $23.16 | - | 2 | Mar 17, 2021 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | n/a | $279.31 | - | 2 | Feb 26, 2021 | |
| DRRX DURECT | Maintains: Buy | n/a | $1.31 | - | 2 | Feb 3, 2021 | |
| ETNB 89bio | Maintains: Buy | n/a | $7.76 | - | 2 | Sep 15, 2020 | |
| VKTX Viking Therapeutics | Maintains: Buy | n/a | $55.32 | - | 2 | Aug 31, 2020 |
Akero Therapeutics
Mar 17, 2021
Maintains: Buy
Price Target: n/a
Current: $23.16
Upside: -
Madrigal Pharmaceuticals
Feb 26, 2021
Maintains: Buy
Price Target: n/a
Current: $279.31
Upside: -
DURECT
Feb 3, 2021
Maintains: Buy
Price Target: n/a
Current: $1.31
Upside: -
89bio
Sep 15, 2020
Maintains: Buy
Price Target: n/a
Current: $7.76
Upside: -
Viking Therapeutics
Aug 31, 2020
Maintains: Buy
Price Target: n/a
Current: $55.32
Upside: -